CG Oncology CGON reported mixed results for the first quarter on Friday. The company posted quarterly losses of 71 cents per ...

CG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street success story is no fluke.

CG Power's growth was led by the power segment, where revenue increased by 50% from last year to ₹1,487 crore led by strong ...

CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will participate in fireside chat ...

CG Power and Industrial Solutions Ltd reported a 32% year-on-year jump in consolidated net profit to Rs 362 crore in the ...

First results from CORE-008 Cohort CX Phase 2 Trial evaluating intravesical combination therapy in High-Risk BCG-Exposed and BCG-Unresponsive patients to be presented- ...

CG Power target price rises to Rs 940 as order book hits Rs 17,100 crore—see why analysts recommend buying now!

What's CG Power & Industrial Solutions Ltd share price today. Get CG Power & Industrial Solutions Ltd latest news on BSE/NSE stock price live updates, CG Power & Industrial Solutions Ltd financial ...

CG Power and Industrial Solutions reported consolidated net profit of ₹362 crore in the quarter ended March 31, FY26, on ...